<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38516932</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication.</ArticleTitle><Pagination><StartPage>1597</StartPage><EndPage>1615</EndPage><MedlinePgn>1597-1615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2024.2330105</ELocationID><Abstract><AbstractText>Many viruses, including foot-and-mouth disease virus (FMDV), can promote the degradation of host proteins through macroautophagy/autophagy, thereby promoting viral replication. However, the regulatory mechanism between autophagy and innate immune responses is not fully understood during FMDV infection. Here, we found that the host GTPBP4/NOG1 (GTP binding protein 4) is a negative regulator of innate immune responses. GTPBP4 deficiency promotes the antiviral innate immune response, resulting in the ability of GTPBP4 to promote FMDV replication. Meanwhile, GTPBP4-deficient mice are more resistant to FMDV infection. To antagonize the host's antiviral immunity, FMDV structural protein VP1 promotes the expression of GTPBP4, and the 209th site of VP1 is responsible for this effect. Mechanically, FMDV VP1 promotes autophagy during virus infection and interacts with and degrades YTHDF2 (YTH N6-methyladenosine RNA binding protein F2) in an AKT-MTOR-dependent autophagy pathway, resulting in an increase in <i>GTPBP4</i> mRNA and protein levels. Increased GTPBP4 inhibits IRF3 binding to the <i>Ifnb/Ifn-β</i> promoter, suppressing FMDV-induced type I interferon production. In conclusion, our study revealed an underlying mechanism of how VP1 negatively regulates innate immunity through the autophagy pathway, which would contribute to understanding the negative regulation of host innate immune responses and the function of GTPBP4 and YTHDF2 during FMDV infection.<b>Abbreviation:</b> 3-MA:3-methyladenine; ACTB: actin beta; ATG: autophagy related; ChIP:chromatin immunoprecipitation; CQ: chloroquine; DAPI:4',6-diamidino-2-phenylindole; dpi: days post-infection; EV71:enterovirus 71; FMDV: foot-and-mouth disease virus; GTPBP4/NOG1: GTPbinding protein 4; HIF1A: hypoxia inducible factor 1 subunit alpha;hpt:hours post-transfection; IFNB/IFN-β:interferon beta; IRF3: interferon regulatory factor 3; MAP1LC3/LC3:microtubule associated protein 1 light chain 3; MAVS: mitochondriaantiviral signaling protein; MOI: multiplicity of infection; MTOR:mechanistic target of rapamycin kinase; m6A: N(6)-methyladenosine;qPCR:quantitativePCR; SIRT3:sirtuin 3; SQSTM1/p62: sequestosome 1; STING1: stimulator ofinterferon response cGAMP interactor 1; siRNA: small interfering RNA;TBK1: TANK binding kinase 1; TCID<sub>50</sub>:50% tissue culture infectious doses; ULK1: unc-51 like autophagyactivating kinase 1; UTR: untranslated region; WT: wild type; YTHDF2:YTH N6-methyladenosine RNA binding protein F2.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huisheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Weijun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiangtao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zixiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Haixue</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494233">Irf3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C442501">VP1 protein, Foot-and-mouth disease virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="C000627066">Ythdc2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="Y">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005536" MajorTopicYN="Y">Foot-and-Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029544" MajorTopicYN="Y">Foot-and-Mouth Disease Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050838" MajorTopicYN="Y">Interferon Regulatory Factor-3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="Y">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">FMDV</Keyword><Keyword MajorTopicYN="N">GTPBP4</Keyword><Keyword MajorTopicYN="N">IRF3</Keyword><Keyword MajorTopicYN="N">MTOR</Keyword><Keyword MajorTopicYN="N">YTHDF2</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38516932</ArticleId><ArticleId IdType="pmc">PMC11210904</ArticleId><ArticleId IdType="doi">10.1080/15548627.2024.2330105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grubman MJ, Baxt B.. Foot-and-mouth disease. Clin Microbiol Rev. 2004. Apr;17(2):465–93. doi: 10.1128/CMR.17.2.465-493.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.17.2.465-493.2004</ArticleId><ArticleId IdType="pmc">PMC387408</ArticleId><ArticleId IdType="pubmed">15084510</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham GJ. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol. 1993;60(3):241–60. doi: 10.1016/0079-6107(93)90016-D</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0079-6107(93)90016-D</ArticleId><ArticleId IdType="pmc">PMC7173301</ArticleId><ArticleId IdType="pubmed">8396787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Sun SQ, Guo HC. Biological function of foot-and-mouth disease virus non-structural proteins and non-coding elements. Virol J. 2016 Jun 22;13(1):107. doi: 10.1186/s12985-016-0561-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0561-z</ArticleId><ArticleId IdType="pmc">PMC4917953</ArticleId><ArticleId IdType="pubmed">27334704</ArticleId></ArticleIdList></Reference><Reference><Citation>CañCañAs-Arranz R, Forner M, Defaus S, et al. A single dose of dendrimer B2T peptide vaccine partially protects pigs against foot-and-mouth disease virus infection. Vaccines. 2020 Jan 10;8(1):19. doi: 10.3390/vaccines8010019</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8010019</ArticleId><ArticleId IdType="pmc">PMC7157199</ArticleId><ArticleId IdType="pubmed">31936706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian K, Yang F, Zhu Z, et al. The VP1 S154D mutation of type Asia1 foot-and-mouth disease virus enhances viral replication and pathogenicity. Infect Genet Evol. 2016. Apr;39:113–119. doi: 10.1016/j.meegid.2016.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2016.01.009</ArticleId><ArticleId IdType="pubmed">26792712</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng JM, Liang SM, Liang CM. VP1 of foot-and-mouth disease virus induces apoptosis via the akt signaling pathway. J Biol Chem. 2004 Dec 10;279(50):52168–74. doi: 10.1074/jbc.M403686200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403686200</ArticleId><ArticleId IdType="pubmed">15466859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekanayaka P, Lee SY, Herath TUB. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation. PLoS Pathog. 2020. Nov;16(11):e1009057. doi: 10.1371/journal.ppat.1009057</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009057</ArticleId><ArticleId IdType="pmc">PMC7723281</ArticleId><ArticleId IdType="pubmed">33232374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao J, Shen C, Wei N, et al. Foot-and-mouth disease virus capsid protein VP1 Antagonizes TPL2-mediated activation of the IRF3/IFN-β signaling pathway to facilitate thevirus replication. Front Immunol. 2020;11:580334. doi: 10.3389/fimmu.2020.580334</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.580334</ArticleId><ArticleId IdType="pmc">PMC7821752</ArticleId><ArticleId IdType="pubmed">33488582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Sun X, Yi C, et al. AGO2 negatively regulates type I interferon signaling pathway by competition binding IRF3 with CBP/p300. Front Cell Infect Microbiol. 2017;7:195. doi: 10.3389/fcimb.2017.00195</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00195</ArticleId><ArticleId IdType="pmc">PMC5438986</ArticleId><ArticleId IdType="pubmed">28589097</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Hamrashdi M, Brady G. Regulation of IRF3 activation in human antiviral signaling pathways. Biochem Pharmacol. 2022. Jun;200:115026. doi: 10.1016/j.bcp.2022.115026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.115026</ArticleId><ArticleId IdType="pubmed">35367198</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb LG, Fernandez-Sesma A. RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing. Curr Opin Virol. 2022. Apr;53:101206. doi: 10.1016/j.coviro.2022.101206</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2022.101206</ArticleId><ArticleId IdType="pubmed">35180533</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurczyszak D, Manganaro L, Buta S. ISG15 deficiency restricts HIV-1 infection. PLOS Pathog. 2022. Mar;18(3):e1010405. doi: 10.1371/journal.ppat.1010405</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010405</ArticleId><ArticleId IdType="pmc">PMC8986114</ArticleId><ArticleId IdType="pubmed">35333911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Liu X, Cheng T. et al. LYAR suppresses beta interferon induction by targeting phosphorylated interferon regulatory factor 3. J Virol. 2019 Nov 1;93(21). doi: 10.1128/JVI.00769-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00769-19</ArticleId><ArticleId IdType="pmc">PMC6803289</ArticleId><ArticleId IdType="pubmed">31413131</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Tian S, Yang J, et al. OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity. Autophagy. 2022. Oct;18(10):2288–2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9542415</ArticleId><ArticleId IdType="pubmed">35100065</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh T, Tun-Kyi A, Ryo A, et al. Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol. 2006. Jun;7(6):598–605.</Citation><ArticleIdList><ArticleId IdType="pubmed">16699525</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017 Feb 2;10(1):5. doi: 10.1186/s13041-017-0287-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran T, Bodda C, Krapp C. et al. Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J. 2018 Apr 13;37(8). doi: 10.15252/embj.201797858</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797858</ArticleId><ArticleId IdType="pmc">PMC5897779</ArticleId><ArticleId IdType="pubmed">29496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X, Yang H, Li T, et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019. Mar;567(7747):262–266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417302</ArticleId><ArticleId IdType="pubmed">30842662</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Mo Y, Peng M, et al. The influence of circular RNAs on autophagy and disease progression. Autophagy. 2022. Feb;18(2):240–253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942425</ArticleId><ArticleId IdType="pubmed">33904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Song X, Li J, et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy. 2023. Jan;19(1):54–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9809962</ArticleId><ArticleId IdType="pubmed">35403545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Li X, Yin M, et al. Selective autophagy receptor SQSTM1/p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3. Autophagy. 2021. Nov;17(11):3763–3775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632295</ArticleId><ArticleId IdType="pubmed">33719859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wang J, Xu D, et al. M 6 a mRNA methylation regulates testosterone synthesis through modulating autophagy in Leydig cells. Autophagy. 2021. Feb;17(2):457–475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007139</ArticleId><ArticleId IdType="pubmed">31983283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Tang B, Xing J, et al. MTA1-mediated RNA m(6) a modification regulates autophagy and is required for infection of the rice blast fungus. New Phytol New Phytol. 2022. Jul;235(1):247–262.</Citation><ArticleIdList><ArticleId IdType="pubmed">35338654</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H, Feng X, Zhang H. METTL3 and ALKBH5 oppositely regulate m 6 a modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019. Aug;15(8):1419–1437. doi: 10.1080/15548627.2019.1586246</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1586246</ArticleId><ArticleId IdType="pmc">PMC6613905</ArticleId><ArticleId IdType="pubmed">30870073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z, Mei W, Qu C, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022 Aug 9;11(1):45. doi: 10.1186/s40164-022-00298-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40164-022-00298-7</ArticleId><ArticleId IdType="pmc">PMC9361621</ArticleId><ArticleId IdType="pubmed">35945641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang D, Lin WJ. m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy. 2022. Jun;18(6):1318–1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9225222</ArticleId><ArticleId IdType="pubmed">34657574</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng S, Zheng W, Wang W. The m6A reader YTHDF2 modulates antiviral and antibacterial activity by suppressing METTL3 methylation-modified STING in fish. J Immunol. 2023 Mar 1;210(5):653–667. doi: 10.4049/jimmunol.2200618</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2200618</ArticleId><ArticleId IdType="pubmed">36645377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WB, Jia WD, Ma JL, et al. Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance. Oncotarget. 2017 Nov 7;8(55):93984–93997. doi: 10.18632/oncotarget.21500</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.21500</ArticleId><ArticleId IdType="pmc">PMC5706849</ArticleId><ArticleId IdType="pubmed">29212203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Yin Y, Yu M, et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 2022. Oct;56:102458. doi: 10.1016/j.redox.2022.102458</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102458</ArticleId><ArticleId IdType="pmc">PMC9483790</ArticleId><ArticleId IdType="pubmed">36116159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Chen G, Wang W. GTPBP4: a new therapeutic target gene promotes tumor progression in non-small cell lung cancer via EMT. J Oncol. 2022;2022:1–11. doi: 10.1155/2022/2164897</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2164897</ArticleId><ArticleId IdType="pmc">PMC9674418</ArticleId><ArticleId IdType="pubmed">36405249</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Xie J, Chen L, et al. Integrated analysis of genomic and transcriptomic profiles identified the role of GTP binding protein-4 (GTPBP4) in breast cancer. Front Pharmacol. 2022;13:880445. doi: 10.3389/fphar.2022.880445</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.880445</ArticleId><ArticleId IdType="pmc">PMC9243593</ArticleId><ArticleId IdType="pubmed">35784753</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouchana L, Fernández-Ramos AA, Dumont F, et al. Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines. Genome Med. 2015;7(1):37. doi: 10.1186/s13073-015-0150-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0150-6</ArticleId><ArticleId IdType="pmc">PMC4443628</ArticleId><ArticleId IdType="pubmed">26015807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen BC, Wang Q, Kifer CT, et al. The NOG1 GTP-binding protein is required for biogenesis of the 60 S ribosomal subunit. J Biol Chem. 2003 Aug 22;278(34):32204–11. doi: 10.1074/jbc.M304198200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M304198200</ArticleId><ArticleId IdType="pubmed">12788953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Huang Z, Huang M. Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflamm. 2020;2020:9273241. doi: 10.1155/2020/9273241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9273241</ArticleId><ArticleId IdType="pmc">PMC7013319</ArticleId><ArticleId IdType="pubmed">32089650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wu C, Wang X, et al. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Autophagy. 2020. Mar;16(3):548–561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6999643</ArticleId><ArticleId IdType="pubmed">31204557</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang F, Li K, et al. The insufficient activation of RIG-I-Like signaling pathway contributes to highly efficient replication of porcine picornaviruses in IBRS-2 cells. Mol Cell Proteomics. 2021;20:100147. doi: 10.1016/j.mcpro.2021.100147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100147</ArticleId><ArticleId IdType="pmc">PMC8503670</ArticleId><ArticleId IdType="pubmed">34530158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Fang L, Liu L, et al. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway. Mol Immunol. 2011. Oct;49(1–2):407–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">21975014</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingauf-Nerurkar P, Gillet LC, Portugal-Calisto D. The GTPase Nog1 co-ordinates the assembly, maturation and quality control of distant ribosomal functional centers. Elife. 2020 Jan 7;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6968927</ArticleId><ArticleId IdType="pubmed">31909713</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Taniguchi T. Irfs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006. Sep;6(9):644–58. doi: 10.1038/nri1900</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1900</ArticleId><ArticleId IdType="pubmed">16932750</ArticleId></ArticleIdList></Reference><Reference><Citation>Manivanh R, Mehrbach J, Knipe DM. et al. Role of herpes simplex virus 1 γ34.5 in the regulation of IRF3 signaling. J Virol. 2017 Dec 1;91(23). doi: 10.1128/JVI.01156-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01156-17</ArticleId><ArticleId IdType="pmc">PMC5686731</ArticleId><ArticleId IdType="pubmed">28904192</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhu Z, Feng T, et al. African swine fever virus E120R protein inhibits interferon beta production by interacting with IRF3 to block its activation. J Virol. 2021 Aug 25;95(18):e0082421. doi: 10.1128/JVI.00824-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00824-21</ArticleId><ArticleId IdType="pmc">PMC8387055</ArticleId><ArticleId IdType="pubmed">34190598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou G, Zhao X, Li L, et al. Sumoylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRnas. Nucleic Acids Res. 2021 Mar 18;49(5):2859–2877. doi: 10.1093/nar/gkab065</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab065</ArticleId><ArticleId IdType="pmc">PMC7969013</ArticleId><ArticleId IdType="pubmed">33577677</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat Commun. 2016 Aug 25;7(1):12626. doi: 10.1038/ncomms12626</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12626</ArticleId><ArticleId IdType="pmc">PMC5007331</ArticleId><ArticleId IdType="pubmed">27558897</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhou X, Wang X. m6A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022 Apr 5;11(1):21. doi: 10.1186/s40164-022-00269-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40164-022-00269-y</ArticleId><ArticleId IdType="pmc">PMC8981655</ArticleId><ArticleId IdType="pubmed">35382893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong N, Shan T, Wang H, et al. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy. Autophagy. 2020. Oct;16(10):1737–1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386623</ArticleId><ArticleId IdType="pubmed">31868081</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wu X, Wang H, et al. HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation. Autophagy. 2021. Aug;17(8):1962–1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386699</ArticleId><ArticleId IdType="pubmed">32746697</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010. May;221(1):3–12. doi: 10.1002/path.2697</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2697</ArticleId><ArticleId IdType="pmc">PMC2990190</ArticleId><ArticleId IdType="pubmed">20225336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Yang C, Iyaswamy A, et al. Balancing mTOR signaling and autophagy in the treatment of Parkinson’s disease. Int J Mol Sci. 2019 Feb 8;20(3):728. doi: 10.3390/ijms20030728</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030728</ArticleId><ArticleId IdType="pmc">PMC6387269</ArticleId><ArticleId IdType="pubmed">30744070</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabanal-Ruiz Y, Otten EG, Korolchuk VI, et al. mTORC1 as the main gateway to autophagy. Essays Biochem. 2017 Dec 12;61(6):565–584. doi: 10.1042/EBC20170027</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20170027</ArticleId><ArticleId IdType="pmc">PMC5869864</ArticleId><ArticleId IdType="pubmed">29233869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming SL, Zhang S, Wang Q, et al. Inhibition of USP14 influences alphaherpesvirus proliferation by degrading viral VP16 protein via ER stress-triggered selective autophagy. Autophagy. 2022. Aug;18(8):1801–1821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9450976</ArticleId><ArticleId IdType="pubmed">34822318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha A, Seago J, Scott K, et al. Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol. 2015. Oct;22(10):788–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5985953</ArticleId><ArticleId IdType="pubmed">26389739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Qu M, et al. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. Autophagy. 2023. Nov;19(11):2869–2883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10549200</ArticleId><ArticleId IdType="pubmed">37408174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Wang J, Mao J, et al. Determining the clinical value and critical pathway of GTPBP4 in lung adenocarcinoma using a bioinformatics strategy: a study based on datasets from the cancer genome atlas. Biomed Res Int. 2020;2020:1–13. doi: 10.1155/2020/5171242</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5171242</ArticleId><ArticleId IdType="pmc">PMC7593728</ArticleId><ArticleId IdType="pubmed">33134380</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Pang X, Zhu Z, et al. GTPBP4 promotes gastric cancer progression via regulating P53 activity. Cell Physiol Biochem. 2018;45(2):667–676. doi: 10.1159/000487160</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000487160</ArticleId><ArticleId IdType="pubmed">29408813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Shen H, Huang S, et al. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma. Eur J Histochem. 2021 Nov 16;65(4). doi: 10.4081/ejh.2021.3300</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejh.2021.3300</ArticleId><ArticleId IdType="pmc">PMC8611415</ArticleId><ArticleId IdType="pubmed">34783233</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduro PK, Zheng X, Wei J, et al. The cGAS–STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022. Jan;12(1):50–75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8799861</ArticleId><ArticleId IdType="pubmed">35127372</ArticleId></ArticleIdList></Reference><Reference><Citation>Deater M, Tamhankar M, Lloyd RE. TDRD3 is an antiviral restriction factor that promotes IFN signaling with G3BP1. PLoS Pathog. 2022. Jan;18(1):e1010249. doi: 10.1371/journal.ppat.1010249</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010249</ArticleId><ArticleId IdType="pmc">PMC8824378</ArticleId><ArticleId IdType="pubmed">35085371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Wang Q, Yang F, et al. JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination. PLoS Pathog. 2021. Mar;17(3):e1009366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971890</ArticleId><ArticleId IdType="pubmed">33684176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z, Cheng X, Sun Z, et al. Grass carp PRMT6 negatively regulates innate immunity by inhibiting the TBK1/IRF3 binding and cutting down IRF3 phosphorylation level. Dev Comp Immunol. 2022. Apr;129:104351. doi: 10.1016/j.dci.2022.104351</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dci.2022.104351</ArticleId><ArticleId IdType="pubmed">35033573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings S, Martínez-Sobrido L, García-Sastre A, et al. Thogoto virus ML protein suppresses IRF3 function. Virology. 2005 Jan 5;331(1):63–72. doi: 10.1016/j.virol.2004.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.10.015</ArticleId><ArticleId IdType="pubmed">15582653</ArticleId></ArticleIdList></Reference><Reference><Citation>Basler CF, Mikulasova A, Martinez-Sobrido L, et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 2003. Jul;77(14):7945–56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC161945</ArticleId><ArticleId IdType="pubmed">12829834</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Q, Liu H, Zhu Z, et al. Seneca Valley virus 3Cpro abrogates the IRF3- and IRF7-mediated innate immune response by degrading IRF3 and IRF7. Virology. 2018. May;518:1–7. doi: 10.1016/j.virol.2018.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.01.028</ArticleId><ArticleId IdType="pubmed">29427864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Yang F, Zhu Z. et al. Cellular DNAJA3, a novel VP1-interacting protein, inhibits foot-and-mouth disease virus replication by inducing lysosomal degradation of VP1 and attenuating its antagonistic role in the beta interferon signaling pathway. J Virol. 2019 Jul 1;93(13). doi: 10.1128/JVI.00588-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00588-19</ArticleId><ArticleId IdType="pmc">PMC6580959</ArticleId><ArticleId IdType="pubmed">30996089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Bio. 2021 Mar 16;22(1):85. doi: 10.1186/s13059-021-02308-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-021-02308-z</ArticleId><ArticleId IdType="pmc">PMC7962360</ArticleId><ArticleId IdType="pubmed">33726814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Zhao Y, Liu Q, et al. DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus. Microbiol Spectr. 2022 Jun 29;10(3):e0109822. doi: 10.1128/spectrum.01098-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01098-22</ArticleId><ArticleId IdType="pmc">PMC9241928</ArticleId><ArticleId IdType="pubmed">35583334</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CS, Zhu YQ, Xu QC, et al. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation. Clin Transl Med. 2022. Jun;12(6):e848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9191870</ArticleId><ArticleId IdType="pubmed">35696608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai RC, Chang YZ, Chang X, et al. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma. J Hematol Oncol. 2021 Jul 10;14(1):109. doi: 10.1186/s13045-021-01124-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-021-01124-z</ArticleId><ArticleId IdType="pmc">PMC8272379</ArticleId><ArticleId IdType="pubmed">34246306</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Liao D, Zhang M, et al. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Lett. 2019 Feb 1;442:252–261. doi: 10.1016/j.canlet.2018.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.11.006</ArticleId><ArticleId IdType="pubmed">30423408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Li C, Du X, et al. Foot-and-mouth disease virus infection inhibits LGP2 protein expression to exaggerate inflammatory response and promote viral replication. Cell Death Dis. 2017 Apr 13;8(4):e2747. doi: 10.1038/cddis.2017.170</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.170</ArticleId><ArticleId IdType="pmc">PMC5477588</ArticleId><ArticleId IdType="pubmed">28406479</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhu Z, Xue Q. et al. Foot-and-mouth disease virus antagonizes NOD2-mediated antiviral effects by inhibiting NOD2 protein expression. J Virol. 2019 Jun 1;93(11). doi: 10.1128/JVI.00124-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00124-19</ArticleId><ArticleId IdType="pmc">PMC6532107</ArticleId><ArticleId IdType="pubmed">30894473</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Xue Q, Zhu Z, et al. Foot-and-mouth disease virus inhibits RIP2 protein expression to promote viral replication. Virol Sin. 2021. Aug;36(4):608–622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379319</ArticleId><ArticleId IdType="pubmed">33400090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkin V, McEwan DG, Novak I, et al. A role for ubiquitin in selective autophagy. Molecular Cell. 2009 May 15;34(3):259–69. doi: 10.1016/j.molcel.2009.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.04.026</ArticleId><ArticleId IdType="pubmed">19450525</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Tian S, Luo M, et al. Tetherin suppresses type I interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells. Molecular Cell. 2017 Oct 19;68(2):308–322.e4. doi: 10.1016/j.molcel.2017.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.09.005</ArticleId><ArticleId IdType="pubmed">28965816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Tang N, Liu P, et al. Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells. Autophagy. 2022. Jul;18(7):1503–1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9298456</ArticleId><ArticleId IdType="pubmed">34720029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou P, Wang X, Wang H, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy. 2023. Feb;19(2):551–569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851267</ArticleId><ArticleId IdType="pubmed">35670302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D, Kong N, Dong S, et al. 2AB protein of senecavirus a antagonizes selective autophagy and type I interferon production by degrading LC3 and MARCHF8. Autophagy. 2022. Aug;18(8):1969–1981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9450971</ArticleId><ArticleId IdType="pubmed">34964697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Zhang S, Qin X, et al. Foot-and-mouth disease virus capsid protein VP2 activates the cellular EIF2S1-ATF4 pathway and induces autophagy via HSPB1. Autophagy. 2018;14(2):336–346. doi: 10.1080/15548627.2017.1405187</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1405187</ArticleId><ArticleId IdType="pmc">PMC5902195</ArticleId><ArticleId IdType="pubmed">29166823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Qu M, et al. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. Autophagy. 2023. Jul;14(11):1–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10549200</ArticleId><ArticleId IdType="pubmed">37408174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhu Z, Xue Q, et al. Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication. PLoS Pathogens. 2023 Feb 3;19(2):e1011126. doi: 10.1371/journal.ppat.1011126</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011126</ArticleId><ArticleId IdType="pmc">PMC9931120</ArticleId><ArticleId IdType="pubmed">36735752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Humes ST, Rose M, et al. Hydroxyl functionalized multi-walled carbon nanotubes modulate immune responses without increasing 2009 pandemic influenza A/H1N1 virus titers in infected mice. Toxicol Appl Pharmacol. 2020 Oct 1;404:115167. doi: 10.1016/j.taap.2020.115167</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2020.115167</ArticleId><ArticleId IdType="pmc">PMC10636740</ArticleId><ArticleId IdType="pubmed">32771490</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang ML, Chiang PS, Luo ST, et al. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. J Virol Methods. 2010. Apr;165(1):42–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20036286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Hu B, Xu J, et al. Influenza A virus infection induces liver injury in mice. Microbial Pathogenesis. 2019. Dec;137:103736. doi: 10.1016/j.micpath.2019.103736</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2019.103736</ArticleId><ArticleId IdType="pmc">PMC7125922</ArticleId><ArticleId IdType="pubmed">31505263</ArticleId></ArticleIdList></Reference><Reference><Citation>Fensterl V, Wetzel JL, Ramachandran S, et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathogens. 2012;8(5):e1002712. doi: 10.1371/journal.ppat.1002712</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002712</ArticleId><ArticleId IdType="pmc">PMC3355090</ArticleId><ArticleId IdType="pubmed">22615570</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Zhu Z, Xue Q, et al. Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release. PLoS Pathog. 2023. Feb;19(2):e1011132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9934381</ArticleId><ArticleId IdType="pubmed">36745686</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, Xu Y, Zhang Y, et al. Human virus-derived small RNAs can confer antiviral immunity in mammals. Immunity. 2017 Jun 20;46(6):992–1004.e5. doi: 10.1016/j.immuni.2017.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.05.006</ArticleId><ArticleId IdType="pubmed">28636969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cresta D, Warren DC, Quirouette C, et al. Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample’s infection concentration. PLoS Comput Biol. 2021 Oct 18;17(10):e1009480. doi: 10.1371/journal.pcbi.1009480</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1009480</ArticleId><ArticleId IdType="pmc">PMC8553042</ArticleId><ArticleId IdType="pubmed">34662338</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Q, Zhu Z, Xue Z, et al. NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLoS Pathogens. 2023. Jul;19(7):e1011511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353805</ArticleId><ArticleId IdType="pubmed">37410776</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Yang W, Yang F, et al. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway. FASEB J. 2016. May;30(5):1757–1766.</Citation><ArticleIdList><ArticleId IdType="pubmed">26813975</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. 10.1038/nprot.2008.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Xu Y, Huo L, et al. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue. PloS One. 2020;15(2):e0228910. doi: 10.1371/journal.pone.0228910</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228910</ArticleId><ArticleId IdType="pmc">PMC7018052</ArticleId><ArticleId IdType="pubmed">32053639</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Xue Q, Cao W, et al. Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication. FASEB J. 2018. Jun 15;32(12):6706–6723. doi: 10.1096/fj.201701351</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201701351</ArticleId><ArticleId IdType="pubmed">29906248</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guo G, Lu M. et al. Long noncoding RNA lnc-MxA inhibits beta interferon transcription by forming RNA-DNA triplexes at its promoter. J Virol. 2019 Nov 1;93(21). doi: 10.1128/JVI.00786-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00786-19</ArticleId><ArticleId IdType="pmc">PMC6803265</ArticleId><ArticleId IdType="pubmed">31434735</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Jiang X, Liu D, et al. Autophagy protects LNCaP cells under androgen deprivation conditions. Autophagy. 2008. Jan;4(1):54–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17993778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>